• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本全科诊所中感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)N501Y变异株患者的临床特征

Clinical Characteristics of Patients with SARS-CoV-2 N501Y Variants in General Practitioner Clinic in Japan.

作者信息

Hanafusa Mariko, Kuramochi Jin, Ishihara Katsutoshi, Honda Makiko, Nawa Nobutoshi, Fujiwara Takeo

机构信息

Department of Global Health Promotion, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan.

Kuramochi Clinic Interpark, Utsunomiya City, Tochigi 321-0114, Japan.

出版信息

J Clin Med. 2021 Dec 14;10(24):5865. doi: 10.3390/jcm10245865.

DOI:10.3390/jcm10245865
PMID:34945159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8708988/
Abstract

The clinical characteristics of patients with N501Y mutation in SARS-CoV-2 variants (N501YV) is not fully understood, especially in the setting of general practice. In this retrospective cohort study, COVID-19 patients admitted to one general practitioner clinic between 26 March and 26 May 2021 were retrospectively analyzed. The characteristics, clinical symptoms and radiological findings before treatment were compared between N501YV and wild-type 501N. Twenty-eight patients were classified as wild-type 501N and 24 as N501YV. The mean (±standard deviation) age was 37.4 (±16.1) years, with no significant difference between groups. Among clinical symptoms, prevalence of fever of 38 degrees Celsius (°C) or higher was significantly higher in the N501YV group than in the wild-type 501N group ( = 0.001). Multivariate analysis showed that fever of 38 °C or higher remained significantly associated with N501YV (adjust odds ratio [aOR]: 6.07, 95% confidence interval [CI]: 1.68 to 21.94). For radiological findings, the lung involvement area was significantly larger in patients infected with N501YV ( = 0.013). In conclusion, in the N501YV group, fever of 38 °C or higher and extensive pneumonia were more frequently observed compared to the wild-type 501N group. There was no significant difference in terms of other demographics and clinical symptoms.

摘要

严重急性呼吸综合征冠状病毒2变体(N501YV)中N501Y突变患者的临床特征尚未完全明确,尤其是在全科医疗环境中。在这项回顾性队列研究中,对2021年3月26日至5月26日期间入住一家全科诊所的新冠肺炎患者进行了回顾性分析。比较了N501YV组和野生型501N组治疗前的特征、临床症状和影像学表现。28例患者被分类为野生型501N,24例为N501YV。平均(±标准差)年龄为37.4(±16.1)岁,两组间无显著差异。在临床症状方面,N501YV组中体温达到或超过38摄氏度(℃)的发热患病率显著高于野生型501N组( = 0.001)。多因素分析显示,体温达到或超过38℃仍与N501YV显著相关(调整优势比[aOR]:6.07,95%置信区间[CI]:1.68至21.94)。对于影像学表现,感染N501YV的患者肺部受累面积显著更大( = 0.013)。总之,与野生型501N组相比,N501YV组中体温达到或超过38℃以及广泛肺炎更为常见。在其他人口统计学和临床症状方面无显著差异。

相似文献

1
Clinical Characteristics of Patients with SARS-CoV-2 N501Y Variants in General Practitioner Clinic in Japan.日本全科诊所中感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)N501Y变异株患者的临床特征
J Clin Med. 2021 Dec 14;10(24):5865. doi: 10.3390/jcm10245865.
2
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France.法国马赛感染不同 SARS-CoV-2 变异株的 COVID-19 患者的临床结局。
Clin Microbiol Infect. 2021 Oct;27(10):1516.e1-1516.e6. doi: 10.1016/j.cmi.2021.05.029. Epub 2021 May 24.
3
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
4
Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China.中国温州地区 2019 冠状病毒病患者低钾血症的评估及其临床特征。
JAMA Netw Open. 2020 Jun 1;3(6):e2011122. doi: 10.1001/jamanetworkopen.2020.11122.
5
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
6
Anesthetic Complications Associated With Severe Acute Respiratory Syndrome Coronavirus 2 in Pediatric Patients.与儿童患者严重急性呼吸综合征冠状病毒 2 相关的麻醉并发症。
Anesth Analg. 2021 Aug 1;133(2):483-490. doi: 10.1213/ANE.0000000000005606.
7
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
8
Clinical characteristics of 71 patients with coronavirus disease 2019.71例2019冠状病毒病患者的临床特征
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jul 28;45(7):790-796. doi: 10.11817/j.issn.1672-7347.2020.200187.
9
The Society for Obstetric Anesthesia and Perinatology Coronavirus Disease 2019 Registry: An Analysis of Outcomes Among Pregnant Women Delivering During the Initial Severe Acute Respiratory Syndrome Coronavirus-2 Outbreak in the United States.产科麻醉与围产医学学会 2019 年冠状病毒病登记处:美国首次严重急性呼吸综合征冠状病毒 2 型爆发期间分娩孕妇结局分析。
Anesth Analg. 2021 Aug 1;133(2):462-473. doi: 10.1213/ANE.0000000000005592.
10
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.

引用本文的文献

1
Association of RBD mutations with COVID-19 disease severity in the Iranian population.伊朗人群中RBD突变与COVID-19疾病严重程度的关联。
Virus Genes. 2025 Jun 26. doi: 10.1007/s11262-025-02168-w.
2
COV2Var, a function annotation database of SARS-CoV-2 genetic variation.COV2Var,一个 SARS-CoV-2 遗传变异的功能注释数据库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D701-D713. doi: 10.1093/nar/gkad958.
3
Applying negative ions and an electric field to countermeasure droplets/aerosol transmission without hindering communication.

本文引用的文献

1
COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study.中国首例 SARS-CoV-2 B.1.1.7 变异株本地传播的 COVID-19 病例可能具有更严重的临床特征:一项前瞻性、对照队列研究。
Microbiol Spectr. 2021 Sep 3;9(1):e0027321. doi: 10.1128/Spectrum.00273-21. Epub 2021 Aug 4.
2
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity.严重急性呼吸综合征冠状病毒2型刺突蛋白L452R变体可逃避免疫细胞并增加传染性。
Cell Host Microbe. 2021 Jul 14;29(7):1124-1136.e11. doi: 10.1016/j.chom.2021.06.006. Epub 2021 Jun 15.
3
应用负离子和电场来对抗飞沫/气溶胶传播,同时不妨碍交流。
Sci Rep. 2023 Aug 26;13(1):13965. doi: 10.1038/s41598-023-40303-5.
Influence of age on the spread of SARS-CoV-2 variant B.1.1.7.
年龄对严重急性呼吸综合征冠状病毒2变异株B.1.1.7传播的影响
J Clin Virol. 2021 Aug;141:104872. doi: 10.1016/j.jcv.2021.104872. Epub 2021 May 27.
4
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France.法国马赛感染不同 SARS-CoV-2 变异株的 COVID-19 患者的临床结局。
Clin Microbiol Infect. 2021 Oct;27(10):1516.e1-1516.e6. doi: 10.1016/j.cmi.2021.05.029. Epub 2021 May 24.
5
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.N501Y 型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶 2(ACE2)及两种强效中和抗体复合物的冷冻电镜结构
PLoS Biol. 2021 Apr 29;19(4):e3001237. doi: 10.1371/journal.pbio.3001237. eCollection 2021 Apr.
6
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021.关注的 SARS-CoV-2 变体 B.1.1.7、B.1.351 或 P.1 的特征:来自七个欧盟/欧洲经济区国家的数据,2020 年第 38 周至 2021 年第 10 周。
Euro Surveill. 2021 Apr;26(16). doi: 10.2807/1560-7917.ES.2021.26.16.2100348.
7
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.评估 SARS-CoV-2 谱系 B.1.1.7 在英国的传播能力。
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.
8
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.202012/1 感染关注的 SARS-CoV-2 变异株的患者的死亡率风险:匹配队列研究。
BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579.
9
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
10
Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia.重症 COVID-19 肺炎患者 6 个月随访的胸部 CT 结果。
Radiology. 2021 Apr;299(1):E177-E186. doi: 10.1148/radiol.2021203153. Epub 2021 Jan 26.